share

3-Bromo-9-Methoxy-5,6,7,8-Tetrahydropyrazolo[5,1-B]Quinazoline CAS NO 1429309-36-3


Unit Price:

CAS No.:1429309-36-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3-Bromo-9-Methoxy-5,6,7,8-Tetrahydropyrazolo[5,1-B]Quinazoline CAS NO 1429309-36-3 is a high-purity, advanced pharmaceutical intermediate belonging to the fused heterocyclic quinazoline class. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block for synthesizing novel bioactive molecules. It is primarily sought after by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of potential drug candidates targeting various therapeutic areas.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization programs due to its versatile reactive sites.
  • Library Synthesis: Employed in the generation of diverse compound libraries for high-throughput screening in drug discovery.
  • Agrochemical Development: Serves as a building block for novel active ingredients in crop protection research.
  • Chemical Biology Probes: Utilized in the development of molecular probes to study biological pathways and enzyme functions.
  • Academic Research: Used in universities and research institutes for fundamental studies in heterocyclic and organic chemistry.

Basic Information

Product Name 3-Bromo-9-Methoxy-5,6,7,8-Tetrahydropyrazolo[5,1-B]Quinazoline
CAS No. 1429309-36-3
Molecular Formula C₁₂H₁₂BrN₃O
Molecular Weight 294.15 g/mol
Synonyms 3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline; 9-Methoxy-3-bromo-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline; Pyrazolo[5,1-b]quinazoline, 3-bromo-9-methoxy-5,6,7,8-tetrahydro-; 1429309-36-3; 3-Br-9-MeO-THPQ; 3-Bromo-9-methoxy-THPQ
EINECS Contact for details

Quality Control

Our 3-Bromo-9-Methoxy-5,6,7,8-Tetrahydropyrazolo[5,1-B]Quinazoline is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP principles where applicable to support our clients' regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to exclude moisture. For long-term storage, consider using desiccants or storing under an inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference standard
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.5%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.